
AstraZeneca antibody cocktail fails to prevent COVID-19 symptoms in trial
Fox News
AstraZeneca’s antibody cocktail failed to prevent COVID-19 symptoms in trial participants recently exposed to the virus, the company announced Monday.
Overall, the company said AZD7442 was found to reduce the risk of developing symptomatic COVID-19 by 33% compared to placebo, "which was not statistically significant." However, the research team was encouraged by results pertaining to patients in the trial who were already infected with COVID-19 at the time of dosing, and said analysis is ongoing.More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












